A Phase 2, Randomised, Open-Label Study of Single Agent Azacitidine (Vidaza) vs. Single Agent MGCD0103 vs. Azacitidine in Combination With MGCD0103 for the treatment of Elderly Subjects With Newly Diagnosed Acute Myeloid Leukaemia or Interm

  • Craddock, Charles (Principal Investigator)

Project Details

Short titleA Phase 2, Randomised, Open-Label Study of Single Agent Azacitidine (Vidaza) vs. Single Agent MGCD0103 vs. Azacitidine in Combination With MGCD0103 for the treatment of Elderly Subjects With Newly Diagnosed Acute Myeloid Leukaemia or Interm
StatusFinished
Effective start/end date1/04/08 → 31/12/12

Funding

  • Queen Elizabeth Hospital Birmingham